Bausch + Lomb exploring several options including a potential sale
Bausch + Lomb Corp. is now considering a sale of the company. The company made this comment after a request by the Canadian Investment Regulatory Organization.
The company's board has given management and its advisors the mandate to explore the possibility of selling the company, which is one of the strategies being considered in the ongoing process of a full spin-off from Bausch Health Companies Inc.
Bausch + Lomb is a healthcare company that offers eye care products, including contact lenses and more than 400 other products. Bausch Health still holds a majority interest of 88% in the company, and a potential sale could lead to a significant transaction.
Shandor Brenner is an American journalist recognized for his sharp and insightful reporting on social and political issues. His work is known for its depth, integrity, and the ability to highlight critical societal concerns.